How mCRC Tumor Sidedness Guides Treatment Decisions

Share:

Conversations on Colorectal Cancer

Science


Guest: Richard Kim, MD Join Dr. Richard Kim of Moffitt Cancer Center as he reveals how the sidedness of a mCRC tumor affects not only the prognosis, but also the biologic you use for each individual patient. Conversations on Colorectal Cancer is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.